share_log

Canaccord Genuity Reiterates Buy on Passage Bio, Maintains $14 Price Target

Moomoo 24/7 ·  Mar 5 09:03

Canaccord Genuity analyst Whitney Ijem reiterates Passage Bio (NASDAQ:PASG) with a Buy and maintains $14 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment